GNA Medical Genetics Center Ltd.

gnamed.com

GNA Medical center is a new, state-of-the-art service provider designated solely to the practice of Genetic Medicine diagnostics. GNA center provides comprehensive, individually customized genetic analysis, employing highly advanced methods and technology known in the field of genetic diagnosis, and a unique concept, the first of its kind in Israel.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

CHARLES RIVER AND VALO HEALTH ANNOUNCE STRATEGIC PARTNERSHIP TO PROVIDE CLIENTS WITH ACCESS TO AI-ENABLED DRUG DISCOVERY SOLUTIONS

Charles River Laboratories International, Inc. and Valo Health, LLC, | January 20, 2022

news image

Charles River Laboratories International, Inc. and Valo Health, LLC, the technology company using human-centric data and computation powered by artificial intelligence (AI) to transform the drug discovery and development process, today announced the formation of a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities to offer a new transformative, AI-enabled drug discovery and d...

Read More

Pharma Tech

SUMITOVANT BIOPHARMA AND SUMITOMO PHARMA ANNOUNCE OFFER TO ACQUIRE OUTSTANDING SHARES OF MYOVANT SCIENCES

Sumitovant Biopharma Ltd. | October 03, 2022

news image

Sumitovant Biopharma Ltd. in conjunction with parent company Sumitomo Pharma Co., Ltd. announced it has submitted a non-binding proposal to the Audit Committee of the Board of Directors of Myovant Sciences Ltd. offering to acquire all outstanding shares of Myovant not already owned by Sumitovant for $22.75 per share in cash. The proposed transaction, if completed, would result in Myovant being delisted from the New York Stock Exchange. The proposed acquisition consideration repres...

Read More

OXYCONTIN MAKER PURDUE PHARMA STARTS AD CAMPAIGN FOR CLAIMS

MSN | February 25, 2020

news image

OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company. The $23.8 million campaign is part of Purdue's bankruptcy proceedings as it tries to resolve close to 3,000 lawsuits over its role in the opioid crisis. Notifying people who may have claims against a company is a standard part of a bankruptcy case. But Purdue’s efforts —worked out with input from a committee of cr...

Read More

Pharmacy Market

BASEBALL LEGEND JOHN SMOLTZ FEATURED ON PLX PHARMA’S SOCIAL CHANNELS

PLx Pharma Inc. | September 13, 2022

news image

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORE 81 mg and VAZALORE 325 mg liquid-filled aspirin capsules has launched a new VAZALORE 325 mg advertising campaign on Facebook featuring legendar...

Read More
news image

Business Insights

CHARLES RIVER AND VALO HEALTH ANNOUNCE STRATEGIC PARTNERSHIP TO PROVIDE CLIENTS WITH ACCESS TO AI-ENABLED DRUG DISCOVERY SOLUTIONS

Charles River Laboratories International, Inc. and Valo Health, LLC, | January 20, 2022

Charles River Laboratories International, Inc. and Valo Health, LLC, the technology company using human-centric data and computation powered by artificial intelligence (AI) to transform the drug discovery and development process, today announced the formation of a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities to offer a new transformative, AI-enabled drug discovery and d...

Read More
news image

Pharma Tech

SUMITOVANT BIOPHARMA AND SUMITOMO PHARMA ANNOUNCE OFFER TO ACQUIRE OUTSTANDING SHARES OF MYOVANT SCIENCES

Sumitovant Biopharma Ltd. | October 03, 2022

Sumitovant Biopharma Ltd. in conjunction with parent company Sumitomo Pharma Co., Ltd. announced it has submitted a non-binding proposal to the Audit Committee of the Board of Directors of Myovant Sciences Ltd. offering to acquire all outstanding shares of Myovant not already owned by Sumitovant for $22.75 per share in cash. The proposed transaction, if completed, would result in Myovant being delisted from the New York Stock Exchange. The proposed acquisition consideration repres...

Read More
news image

OXYCONTIN MAKER PURDUE PHARMA STARTS AD CAMPAIGN FOR CLAIMS

MSN | February 25, 2020

OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company. The $23.8 million campaign is part of Purdue's bankruptcy proceedings as it tries to resolve close to 3,000 lawsuits over its role in the opioid crisis. Notifying people who may have claims against a company is a standard part of a bankruptcy case. But Purdue’s efforts —worked out with input from a committee of cr...

Read More
news image

Pharmacy Market

BASEBALL LEGEND JOHN SMOLTZ FEATURED ON PLX PHARMA’S SOCIAL CHANNELS

PLx Pharma Inc. | September 13, 2022

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORE 81 mg and VAZALORE 325 mg liquid-filled aspirin capsules has launched a new VAZALORE 325 mg advertising campaign on Facebook featuring legendar...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us